Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9567 versus prednisolone in active rheumatoid arthritis
NL-OMON47882Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mizacorat in rheumatoid arthritis (RA), sponsored by AstraZeneca. Primary endpoint: Change from baseline in DAS28-CRP. Started Jan 2018; status: completed.
02
Drugs
mizacorat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON47882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47882.